home / stock / phat / phat news


PHAT News and Press, Phathom Pharmaceuticals Inc. From 02/16/24

Stock Information

Company Name: Phathom Pharmaceuticals Inc.
Stock Symbol: PHAT
Market: NYSE

Menu

PHAT PHAT Quote PHAT Short PHAT News PHAT Articles PHAT Message Board
Get PHAT Alerts

News, Short Squeeze, Breakout and More Instantly...

PHAT - MVIS, IRDM and GRTS are among after hour movers

2024-02-16 16:37:46 ET Gainers: Iovance Biotherapeutics ( IOVA ) +4% . Microvision ( MVIS ) +3% . Iridium Communications  ( IRDM ) +3% . Playtika Holding  ( PLTK ) +2% . JetBlue Airways  ( JBLU ) +2% . Losers...

PHAT - US Companies Moving the Markets, Evening edition
Fri, Feb 16, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $11.595 on volume of 119,263,238 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.8% to $4.3323 on volume of 111,414,526 shares SoundHound AI Inc. (SOUN) rose 0.0% to $3.7601 on volu...

PHAT - Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients

One of the largest pharmacy benefit management (PBM) companies in the United States has added VOQUEZNA (vonoprazan) tablets to its national formularies for commercial plans, effective immediately FLORHAM PARK, N.J., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq...

PHAT - Long Term Trading Analysis for (PHAT)

2024-02-01 06:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PHAT - Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

FLORHAM PARK, N.J., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fires...

PHAT - Phathom Pharmaceuticals says Takeda Pharmaceutical sold 3.7M shares

2024-01-25 11:13:47 ET More on Phathom Pharmaceuticals Phathom Pharma Is A Buy Before July PDUFA Phathom Pharmaceuticals expands existing loan and security deal with Hercules Capital Phathom Pharma heartburn drug undergoes FDA review Read the full article o...

PHAT - Trend Tracker for (PHAT)

2024-01-10 16:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PHAT - Phathom Pharma Is A Buy Before July PDUFA

2024-01-01 06:41:03 ET Summary Phathom Pharmaceuticals' stock is down 35% from its August highs and is now trading at $9. The company has two approved indications for its drug vonoprazan and an upcoming PDUFA. Phathom has a cash balance of $213mn and a cash runway of 8-9 quart...

PHAT - Phathom Pharmaceuticals expands existing loan and security deal with Hercules Capital

2023-12-14 10:06:03 ET More on Hercules Capital, Phathom Pharmaceuticals, etc. Main Street Capital Vs. Hercules Capital: Why Choose? Hercules Capital: This 10% Yield Is Solidly Covered By NII (Upgrade) Hercules Capital: 10% Yield, My Largest BDC Position Phat...

PHAT - Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital

Amendment provides more favorable terms including a 14-month extension of the interest-only period and maturity date until December 2027 Up to an additional $100 million in non- dilutive capital available subject to the achievement of certain revenue milestones Cash runway...

Previous 10 Next 10